To investigate whether DSG2 expression level may affect ONCOS‐102 replication in patients with tumors, we retrospectively analyzed data from tumor biopsy and blood samples from the previously reported ONCOS‐102 phase I clinical trial NCT01598129.28 The gene discussed is DSG2; the disease is neoplasm.